Invention Grant
- Patent Title: Hepatitis C virus inhibitors
-
Application No.: US14021686Application Date: 2013-09-09
-
Publication No.: US08846023B2Publication Date: 2014-09-30
- Inventor: Carol Bachand , Makonen Belema , Daniel H. Deon , Andrew C. Good , Jason Goodrich , Clint A. James , Rico Lavoie , Omar D. Lopez , Alain Martel , Nicholas A. Meanwell , Van N. Nguyen , Jeffrey Lee Romine , Edward H. Ruediger , Lawrence B. Snyder , Denis R. St. Laurent , Fukang Yang , David R. Langley , Gan Wang , Lawrence G. Hamann
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: C07D403/14
- IPC: C07D403/14 ; C07D405/14 ; C07D417/14 ; A61K31/506 ; A61K31/4178 ; A61K31/427 ; A61K31/13 ; A61K31/7105 ; A61K31/4745 ; A61K31/7056 ; A61K38/20 ; A61K38/21 ; C07D401/14
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Public/Granted literature
- US20140017195A1 Hepatitis C Virus Inhibitors Public/Granted day:2014-01-16
Information query
